definiens: shall mean a product that c ontains an Aptamer, other than an Excluded Aptamer, with Anti - Fibrin Activity, and that has, a s another component, a nucleic acid that has Anti - F ibrin Antidote Activity, wherein the discovery, developme nt, manufacture, use, sale or importation of such p roduct would infringe a Valid Claim within the Licensed Pa tent Rights but for the grant and continuing validi ty of the license granted by [COMPANY] to Regado in Section 2 . 1 hereof . In addition, if Regado manufactures, uses, sells, offers for sale, has sold or imports a product that would constitute a Licensed Product but for the fa ct that Regado did not discover or develop the Aptamer cont ained within such product, then, that product shall be deemed to be within the definition of the term for all purposes hereunder . For avoi dance of doubt, in addition to the foregoing requirements, a product must have therapeutically significant leve ls of both Anti - Fibrin Activity and Anti - Fibrin Antidote Activ ity in order to be a 1.19 shall mean ( a ) those certain patent applications and patents listed on Schedule A hereto and any patent or paten t application claiming priority therefrom ; ( b ) all patents that have issued or in the future issue from such patent applications, including utility, model and design patents and certificates of invention ; and ( c ) all divisionals, continuations, continuations - in - part, reissues, re newals, extensions or foreign counterparts or additions to any such patent applications and patents